Partial Breast Irradiation using adaptive MRgRT

Similar documents
Stereotactic MR-guided adaptive radiation therapy (SMART) for locally advanced pancreatic tumors

ACCELERATED BREAST IRRADIATION EVOLVING PARADIGM FOR TREATMENT OF EARLY STAGE BREAST CANCER

Current Status of Accelerated Partial Breast Irradiation. Julia White MD Professor, Radiation Oncology

NSABP PROTOCOL B-39B RTOG PROTOCOL 0413

IORT What We ve Learned So Far

Treatment Planning for Breast Cancer: Contouring Targets. Julia White MD Professor

Partial Breast Irradiation for Breast Conserving Therapy

Linac Based SBRT for Low-intermediate Risk Prostate Cancer in 5 Fractions: Preliminary Report of a Phase II Study with FFF Delivery

Hypofractionated Radiotherapy for breast cancer: Updated evidence

Técnicas y tipos de implantes intersticiales. Mauricio Cambeiro Oncología Radioterápica Clínica Universidad de Navarra

Practical implementation of MR-guided RT: pancreatic SBRT as an example site

RADIOTHERAPY IN BREAST CANCER :

Accelerated Partial Breast Irradiation

Evaluation of three APBI techniques under NSABP B-39 guidelines

San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy

Advances in Localized Breast Cancer

Brachytherapy: The precise answer for tackling breast cancer. Because life is for living

Kenny Guida, DMP, DABR March 21 st, 2015

Brachytherapy is better than external beam therapy for partial breast irradiation

Accelerated Partial Breast Irradiation. Dr Patricia Lillis MD, MHA,MSS Marshfield Clinic Radiation Oncology

Post-Lumpectomy Radiation Techniques and Toxicities

Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer

Accelerated Partial Breast Irradiation: Potential Roles Following Breast-Conserving Surgery

Radiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging

Protocol of Radiotherapy for Breast Cancer

First results from the clinically controlled randomized DBCG PBI trial

Intraoperative. Radiotherapy

7/28/2012. Hania Al-Hallaq, Ph.D. Assistant Professor Radiation Oncology The University of Chicago ***No disclosures***

Breast Brachytherapy: How to Allay Fears of Patients and Colleagues, and What Are Our Expectations for the Future?

Accelerated partial breast irradiation using external beam conformal radiation therapy: A review

Breast Conservation Therapy

Accelerated Radiation Treatment for Early Stage Breast Cancer. update and perspective

Clinical Trials of Proton Therapy for Breast Cancer. Andrew L. Chang, MD 張維安 Study Chair

Breast cancer. (early and advanced) Radiotherapy

Nitesh N. Paryani, M.D. First Radiation & Oncology Group Instructor of Radiation Oncology, Mayo Clinic Courtesy Professor, University of Florida

Clinical experience with TomoDirect System Tangential Mode

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Why Choose Brachytherapy and Not External Beam RT or IORT?

Oral cavity cancer Post-operative treatment

Objectives Intraoperative Radiation Therapy for Early Stage Breast Cancer

1. Screening, Diagnosis and Surgical Management of Breast Cancer

Accelerated Radiation Treatment for Early Stage Breast Cancer. update and perspective

Radiotherapy Management of Breast Cancer Treated with Neoadjuvant Chemotherapy. Julia White MD Professor, Radiation Oncology

Breast Cancer Radiotherapy: Clinical challenges in 2011 from a European Perspective. Dr DA WHEATLEY CONSULTANT ONCOLOGIST ROYAL CORNWALL HOSPITAL

Consensus Guideline on Accelerated Partial Breast Irradiation

Radiation Therapy for breast with Tomotherapy: When?

Accelerated Partial Breast Irradiation FACTS & MYTHS

How can we Personalize RT as part of Breast-Conserving Therapy?

Johannes C. Athanasios Dimopoulos

Principles of breast radiation therapy

How can surgeons help the Radiation Oncologists?

Recent Advances in Breast Radiotherapy

Clinical outcomes of patients treated with accelerated partial breast irradiation with high-dose rate brachytherapy: Scripps Clinic experience

DOES RADIOTHERAPY TECHNIQUE / DOSE / FRACTIONATION REALLY MATTER? YES

Department of Radiation Oncology SMART. Stereotactic MR-guided adaptive radiotherapy. Marloes Jeulink Omar Bohoudi

ASTRO econtouring for Lymphoma. Stephanie Terezakis, MD

Changing Paradigms in Radiotherapy

The Impact of Image Guided Radiotherapy in Breast Boost Radiotherapy

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

A New Standard of Care. ASTRO 2017 Update (NASDAQ: VRAY) 1

AccuBoost non invasive, real-time, image guided breast boosting

Surgery for Breast Cancer

HDR vs. LDR Is One Better Than The Other?

BREAST CONSERVATION TREATMENT IN EARLY STAGE DISEASE AND DCIS LAWRENCE J. SOLIN, MD, FACR, FASTRO

Corporate Medical Policy

Radiotherapy Considerations in Extremity Sarcoma

MRI Applications in Radiation Oncology:

PRONE BREAST WHAT S THE BIG DEAL? Rachel A. Hackett CMD, RTT

Oral Cavity Cancer Combined modality therapy

Carol Marquez, M.D. Department of Radiation Medicine OHSU

Overview of Advanced Techniques in Radiation Therapy

Evolution of radiotherapy techniques in breast conservation treatment

8/1/2017. Clinical Indications and Applications of Realtime MRI-Guided Radiotherapy

Hypofractionated RT in Cervix Cancer. Anuja Jhingran, MD

Future Directions in Prostate Cancer: The Case for Protons. John J. Coen, MD Helen & Harry Gray Cancer Center

Seroma change during magnetic resonance imaging-guided partial breast irradiation and its clinical implications

THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS

External Beam Radiotherapy for Prostate Cancer

New Technologies in Radiation Oncology. Catherine Park, MD, MPH Advocate Good Shepherd Hospital

8/3/2016. Outline. Site Specific IGRT Considerations for Clinical Imaging Protocols. Krishni Wijesooriya, PhD University of Virginia

Prone Breast, Pre- Surgery. A case study; The OSU Way.

REVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria

From position verification and correction to adaptive RT Adaptive RT and dose accumulation

Practice teaching course on head and neck cancer management

Implementation of advanced RT Techniques

Outline. Contour quality control. Dosimetric impact of contouring errors and variability in Intensity Modulated Radiation Therapy (IMRT)

New Technologies for the Radiotherapy of Prostate Cancer

BREAST CONSERVATION TREATMENT IN EARLY STAGE DISEASE AND DCIS LAWRENCE J. SOLIN, MD, FACR, FASTRO

Stereotactic MR-guided adaptive radiotherapy for central lung tumors. Professor Suresh Senan, VU University Medical Center

Radiation Therapy for Soft Tissue Sarcomas

Clinical Implications Of Dose Summation And Adaptation

Citation for published version (APA): Laan, H. P. V. D. (2010). Optimising CT guided radiotherapy for breast cancer Groningen: s.n.

Implementation of Hybrid IMRT Breast Planning

IMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia

Advances in external beam radiotherapy

Guidelines for the treatment of Breast cancer with radiotherapy v.1.0 September 2017

Introduction. Keywords Breast cancer, accelerated partial breast irradiation, 3D conformal radiotherapy, brachytherapy, conservative surgery

The Evolution of RT Techniques for Gynaecological Cancers in a developing country context

Has radiotherapy the potential being focal?

The Physics of Oesophageal Cancer Radiotherapy

Transcription:

Partial Breast Irradiation using adaptive MRgRT Shyama Tetar, radiation-oncologist VUmc Amsterdam 15-12-2017 5 th Vumc SBRT symposium 2017

Current practice Breast conserving treatment (BCT) Breast conserving surgery (BCS)/ lumpectomy Postoperative Whole Breast Irradiation o Hypofractionation: 16x 2.67Gy o Indication boost: 21x 2.20Gy breast + 21x 2.67Gy SIB

Current practice: treatment planning SIB

Rationale: Partial Breast Irradiation Majority of local recurrences occur in proximity to the tumor bed Less than 20% appear elsewhere in the breast Absolute number of failures is very low (<1%/year) Failures elsewhere are likely to be new primary breast cancer o Arose after initial therapy o Would not have been prevented by WBI Smith 2009, IJROBP

Benefits of Partial Breast Irradiation Smaller treatment volume Higher dose per fraction Shorter radiotherapy scheme Less number of fractions, for example 5x From 3-4 wk to a few days/ 1 week/ 1.5 weeks Less radiation exposure to OAR Breasts, Skin, Lungs, Heart Less toxicity Better cosmesis Recurrence/New Primary tumor, consider BCT again

Different Techniques for PBI Intra-operative radiotherapy Intra-cavitaryballoon brachytherapy Interstitial multi-catheter brachytherapy External beam RT

EBRT: Partial Breast Irradiation Florence-trial: RCT: WBI vs PBI, n= 520 pt WBI: 25 x 2 Gy + boost 5 x 2 Gy PBI: 5 x 6 Gy in 2wk, 4-5 coplanar 6MV beams, IMRT-technique IBTR @ 5jr: both groups 1,5% Significantly better toxicity (acute & late) and cosmesis above WBI External beam radiotherapy (EBRT): Dosimetric evaluation No invasive treatment Outpatient treatment / short duration Ipsilateral breast tumor recurrence minimal Livi, 215, EJC

Ongoing trial: NSABP B-39/RTOG 0413 A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) vs Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer WBI 50-50,4Gy optional boost 60-66,6Gy PBI twice daily EBRT: 10 x 3,85 Gy Brachy: 10 x 3,4Gy Preliminary data (2008): 3311pt, median follow-up @ 19 months o No higher risk severe toxicity with EBRT Smith 2009, IJROPB Norris 2008

MRI-guided radiotherapy

Benefits of MRIdian versus CBCT Soft-tissue setup superior Setup on clips vs setup with MRI Real-time imaging and online gating Only 3mm PTV margin around CTV Adaptive plan optimization on surgical cavity Change of: seroma / position breast PARLOB Partial Breast Radiotherapy in Low-risk Breast cancer group using a MR-guided adaptive approach; a phase II study

Population: low risk good candidates/suitable GEC-ESTRO recommendation ASTRO consensus statement Polgar 2010, RO Smith 2009, IJROBP

Population: low risk GEC-ESTRO recommendation

PARLOB study: Prospective phase II Endpoints: PE: Toxicity in 1.5 year SE: Cosmesis, QoL Inclusion: low risk breast cancer N= 50 pt Treatment: 5 fracties of 6Gy or 6.5Gy Hypothesis: low tox / better cosmesis Combination of MRI-guided adaptive radiotherapy with smaller PTV-margin ensure no increasing toxicity with higher dose per fraction

PARLOB: Cosmetic outcome BCCT.core software Patient self-evluation questionnaire Breast shape Breast volume Deformity Nipple position Scar visibility Skin changes Panel evaluation Breast surgeon Plastic surgeon Layperson Haloua 2014, IJBC Cardoso 2007, The Breast

Treatment workflow PARLOB Consult + simulation (ipsilateral arm up) breath-hold in 17 sec 0,35T MR sim + CT sim Target volume and OAR delineation + Baseline treatment plan CTV= surgical cavity + isotropic margin of 1.5 cm PTV= CTV + 3mm Planning constraints conform RTOG 0413/NSABP B-39 Treatment 0,35 T MRI-scan + recontour deformed OAR Reoptimize baseline plan on current anatomy of the day MRgRT delivery with multiple breath-holds

PT1 PT2 PT3 PT4

Video feedback system for breath-hold Total treatment duration from setup: about 61 minutes Photography by Digidaan

PBI on the MRIdian

Take home messages PBI using adaptive MR guidance is feasible Accrual runs successfully Not everypatient needs activebreath-hold Challenges to expect Different location o Medial à constraints heart and contralateral breast / lung o Lateral à image quality